Qube Research & Technologies LTD Myriad Genetics Inc Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Myriad Genetics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2,051,588 shares of MYGN stock, worth $13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,051,588
Previous 1,418,149
44.67%
Holding current value
$13 Million
Previous $12.6 Million
13.4%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding MYGN
# of Institutions
235Shares Held
95.6MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$95.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$58.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$31.2 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$30.4 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$29 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $510M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...